✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
PF-04447943 is an investigational drug.
There have been 8 clinical trials for PF-04447943. The most recent clinical trial was a Phase 2 trial, which was initiated on September 10th 2009.
The most common disease conditions in clinical trials are Alzheimer Disease and [disabled in preview]. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Recent Clinical Trials for PF-04447943
|A Study To Evaluate The Effect Of PF-04447943 On Qtc Interval In Healthy Adult Subjects||Pfizer||Phase 1|
|A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Of PF-04447943 When Administered With Donepezil To Healthy Volunteer Subjects||Pfizer||Phase 1|
|A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease||Pfizer||Phase 1|